INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 46 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,000 | -99.8% | 6,000 | -99.8% | 0.00% | – |
| Q1 2021 | $3,031,000 | +18.0% | 2,723,000 | +19.0% | 0.00% | – |
| Q4 2020 | $2,568,000 | +31.1% | 2,288,000 | +26.8% | 0.00% | – |
| Q3 2020 | $1,959,000 | +24.8% | 1,805,000 | +11.8% | 0.00% | – |
| Q2 2020 | $1,570,000 | +37.7% | 1,615,000 | +18.3% | 0.00% | – |
| Q1 2020 | $1,140,000 | +1.6% | 1,365,000 | +17.2% | 0.00% | – |
| Q4 2019 | $1,122,000 | +6.5% | 1,165,000 | -7.9% | 0.00% | – |
| Q3 2019 | $1,054,000 | +4.4% | 1,265,000 | +21.6% | 0.00% | – |
| Q2 2019 | $1,010,000 | -3.8% | 1,040,000 | 0.0% | 0.00% | – |
| Q1 2019 | $1,050,000 | +29.3% | 1,040,000 | -8.8% | 0.00% | – |
| Q4 2018 | $812,000 | +5.5% | 1,140,000 | +24.6% | 0.00% | – |
| Q3 2018 | $770,000 | +26.2% | 915,000 | +37.6% | 0.00% | – |
| Q2 2018 | $610,000 | -22.0% | 665,000 | -25.3% | 0.00% | – |
| Q1 2018 | $782,000 | – | 890,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sycale Advisors (NY) LLC | 8,065,000 | $9,173,000 | 6.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 61,000,000 | $69,219,000 | 1.37% |
| Sonora Investment Management, LLC | 6,645,000 | $7,519,000 | 0.62% |
| ZAZOVE ASSOCIATES LLC | 4,377,000 | $4,951,000 | 0.61% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 22,362,000 | $25,324,000 | 0.54% |
| SSI INVESTMENT MANAGEMENT LLC | 6,532,000 | $7,328,000 | 0.52% |
| Context Capital Management, LLC | 2,163,000 | $2,438,000 | 0.33% |
| WOLVERINE ASSET MANAGEMENT LLC | 35,070,000 | $39,493,000 | 0.29% |
| Cheyne Capital Management (UK) LLP | 450,000 | $509,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 32,500,000 | $36,552,000 | 0.22% |